D25 can gives weakness, vertigo blindness of eye

Reading File
Finding Sources
Finding Sources
Searching the Web

D25 dextrose 25% infusion side effects weakness vertigo blindness neurological

Finding Sources
Finding Sources
Reading Web Page

D25 dextrose weakness vertigo blindness neurological side effects

Finding Sources
Finding Sources
Reading File
I now have solid textbook evidence. Here is a thorough answer:

Can D25 (Dextrose 25%) Cause Weakness, Vertigo, and Blindness?

Yes - all three can occur, primarily through the metabolic and osmotic consequences of the concentrated glucose load. Here is how each happens:

Mechanisms

1. Hyperglycemia and Hyperosmolarity

D25 is a hypertonic solution (250 mg/mL of glucose). When infused, it rapidly raises blood glucose and serum osmolality. This creates several problems:
  • Osmolality can exceed 330 mOsm/L in at-risk patients
  • Cerebral dehydration occurs as water shifts out of brain cells into the hyperosmolar blood
  • Hemoconcentration and prerenal azotemia follow
This is well-documented as Hyperosmolar Nonketotic Hyperglycemia - a syndrome where neurological signs are more prominent than in almost any other metabolic encephalopathy.

2. Weakness

Several pathways lead to muscle weakness:
CauseMechanism
Hyperglycemic encephalopathyCNS fatigue, stupor, hemiparesis
HypokalemiaDextrose drives K+ into cells (transcellular shift), causing muscle weakness and cramps
Refeeding syndromeIn malnourished/starved patients, rapid glucose load drops phosphate and magnesium, causing profound muscle weakness
Fluid/electrolyte imbalanceHyponatremia from free water excess (dilutional)
The textbook describes the classic picture of DKA/hyperosmolar states: "dehydration, fatigue, weakness, headache... stupor or coma" - Adams and Victor's Neurology.

3. Vertigo (Dizziness)

  • Hyperosmolarity - affects vestibular and cerebellar function
  • Hyponatremia - dilutional hyponatremia from dextrose metabolism (each gram of dextrose metabolized generates free water) can cause vertigo, nausea, and confusion
  • Intracranial pressure changes - dextrose can worsen cerebral edema, raising ICP, which impairs brainstem/cerebellar function
  • Rapid glucose correction - if given after prolonged hypoglycemia, the osmolality reversal gradient causes brain edema

4. Visual Disturbances / Blindness

This is the most serious complication:
  • Homonymous visual field defects are specifically documented in hyperosmolar hyperglycemia - the textbook states: "Seizures and focal signs such as hemiparesis, hemisensory defect, choreoathetosis, or a homonymous visual field defect are more common than in any other metabolic encephalopathy" - Adams and Victor's Principles of Neurology, 12th Ed.
  • Cerebral edema from rapid correction of hyperglycemia impairs occipital cortex perfusion
  • Osmotic fluid shifts in the lens of the eye cause transient blurred vision/refractive changes - a well-known effect of rapid blood glucose changes
  • Increased intracranial pressure can compress the optic nerve or disrupt visual pathways

Who Is Most At Risk?

  • Neonates and infants (D25 is commonly used in NICUs - risk of IVH and cerebral injury)
  • Diabetic patients - poor glucose tolerance amplifies hyperglycemia
  • Malnourished/starved patients - risk of refeeding syndrome
  • Elderly patients - reduced renal clearance, pre-existing vascular disease
  • Patients with pre-existing cerebral injury - dextrose infusion significantly worsens ischemic brain injury (documented in studies)

Key Safety Points

  1. Never give D25 rapidly - slow controlled infusion is mandatory
  2. Monitor blood glucose frequently during infusion
  3. Check electrolytes (K+, Na+, Phosphate, Magnesium) before and during use
  4. Use a central line if possible to avoid vein damage and extravasation
  5. Taper slowly when stopping to prevent rebound hypoglycemia
  6. Avoid in patients with stroke/brain ischemia - hyperglycemia worsens cerebral infarction

So yes - D25 is a potent solution that must be used with caution. The weakness, vertigo, and visual loss you mention are real, documented neurological effects arising from hyperosmolarity, electrolyte shifts, cerebral edema, and focal neurological deficits caused by hyperglycemic encephalopathy.
Source: Adams and Victor's Principles of Neurology, 12th Edition - "Hyperglycemic Encephalopathy"

If bp is normal like 110/70 and rbs 110 can given ??

Finding Sources
Finding Sources
Searching the Web

D25 dextrose 25% indication normal blood glucose RBS contraindicated

Short Answer: Generally NO - D25 should NOT be given when RBS is 110 mg/dL (normal)

Here is the clinical reasoning:

Why D25 is Not Indicated Here

The Core Indication of D25 is Hypoglycemia ONLY

D25 (Dextrose 25%) is indicated exclusively for treatment of symptomatic hypoglycemia:
  • FDA approved indication: "treatment of acute symptomatic episodes of hypoglycemia"
  • The trigger for D25 is typically RBS < 70 mg/dL (symptomatic hypoglycemia)
  • RBS of 110 mg/dL is normal - there is no glucose deficit to correct

What Happens if You Give D25 at RBS 110?

EffectResult
Blood glucose will rise sharplyFrom 110 → easily 200-300+ mg/dL
Hyperosmolar stateSerum osmolality rises, water shifts out of cells
Cerebral dehydrationCauses exactly the weakness, vertigo, visual changes we discussed
Reactive hyperinsulinemiaFollowed by rebound hypoglycemia
Electrolyte shiftK+ drops (hypokalemia) - more weakness

BP 110/70 is Irrelevant to D25 Indication

  • Normal BP does not indicate a need for glucose
  • D25 is not a vasopressor or fluid resuscitator
  • If the concern is volume status, NS or RL is the appropriate fluid, not D25

When Would D25 Be Acceptable Despite Normal-ish RBS?

There are very limited exceptions:
  1. As a vehicle for drug infusion - some IV drugs (e.g., certain antibiotics, amiodarone in some protocols) are diluted in dextrose, but this is a tiny volume, not a full D25 bolus
  2. Parenteral nutrition - D25 as a caloric component in TPN, carefully calculated with other nutrients
  3. Hyperkalemia treatment - dextrose + insulin to shift K+ into cells, but even then RBS is monitored closely and D10 is often preferred

Clinical Bottom Line

BP 110/70 + RBS 110 = D25 is contraindicated / not indicated.
Giving D25 in this setting would be iatrogenic harm - you would be creating hyperglycemia in a patient with normal glucose, which risks all the neurological complications discussed: weakness, vertigo, and visual disturbances.
If the patient is symptomatic and you need IV fluids, use Normal Saline (NS 0.9%) or Ringer's Lactate instead.
This is a shared conversation. Sign in to Orris to start your own chat.